JBT Marel Corp's Q3 Revenue Surges

By Chris Stiles • Wednesday, February 18 11:25 • Permanent Link

In the first quarter of 2025, JBT Marel's Protein Solutions segment generated $377.7 million in revenue, while Prepared Food and Beverage Solutions brought in $476.4 million. By the second quarter, these figures had increased to $421.5 million for Protein Solutions and $513.3 million for Prepared Food and Beverage Solutions. The trend continued in the third quarter, with revenue reaching $440.8 million for Protein Solutions and $560.5 million for Prepared Food and Beverage Solutions.

Looking at the Segment Adjusted EBITDA, the first quarter saw a combined total of $140.6 million, with Protein Solutions at $62.5 million and Prepared Food and Beverage Solutions at $78.1 million. By the second quarter, the total had risen to $179.7 million, with Protein Solutions contributing $86.2 million and Prepared Food and Beverage Solutions at $93.5 million. In the third quarter, the total Segment Adjusted EBITDA further increased to $196.4 million, with Protein Solutions at $94.0 million and Prepared Food and Beverage Solutions at $102.4 million.

Comparing these figures to the full year of 2024, the positive trend is evident. In 2024, Protein Solutions reported a total Segment Adjusted EBITDA of $57.5 million, which significantly increased to $94.0 million by the third quarter of 2025. Similarly, Prepared Food and Beverage Solutions saw a substantial rise from $301.2 million in 2024 to $102.4 million in the third quarter of 2025.

Today the company's shares have moved -0.12% to a price of $158.88. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.